313 related articles for article (PubMed ID: 7752246)
1. The crystal structure of the N-terminal SH3 domain of Grb2.
Guruprasad L; Dhanaraj V; Timm D; Blundell TL; Gout I; Waterfield MD
J Mol Biol; 1995 May; 248(4):856-66. PubMed ID: 7752246
[TBL] [Abstract][Full Text] [Related]
2. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of the Grb2 N-terminal SH3 domain complexed with a ten-residue peptide derived from SOS: direct refinement against NOEs, J-couplings and 1H and 13C chemical shifts.
Wittekind M; Mapelli C; Lee V; Goldfarb V; Friedrichs MS; Meyers CA; Mueller L
J Mol Biol; 1997 Apr; 267(4):933-52. PubMed ID: 9135122
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular analysis of Grb2 SH3 domain mutants: interaction with Sos and dynamin.
Vidal M; Goudreau N; Cornille F; Cussac D; Gincel E; Garbay C
J Mol Biol; 1999 Jul; 290(3):717-30. PubMed ID: 10395825
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
Pisabarro MT; Serrano L; Wilmanns M
J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of Grb2 reveals extensive flexibility necessary for target recognition.
Yuzawa S; Yokochi M; Hatanaka H; Ogura K; Kataoka M; Miura K; Mandiyan V; Schlessinger J; Inagaki F
J Mol Biol; 2001 Feb; 306(3):527-37. PubMed ID: 11178911
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
McDonald CB; Seldeen KL; Deegan BJ; Farooq A
Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
[TBL] [Abstract][Full Text] [Related]
10. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2.
Xu XX; Yi T; Tang B; Lambeth JD
Oncogene; 1998 Mar; 16(12):1561-9. PubMed ID: 9569023
[TBL] [Abstract][Full Text] [Related]
11. Competitive binding assay of src homology domain 3 interactions between 5-lipoxygenase and growth factor receptor binding protein 2.
VanderNoot VA; Fitzpatrick FA
Anal Biochem; 1995 Sep; 230(1):108-14. PubMed ID: 8585605
[TBL] [Abstract][Full Text] [Related]
12. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures.
Larson SM; Davidson AR
Protein Sci; 2000 Nov; 9(11):2170-80. PubMed ID: 11152127
[TBL] [Abstract][Full Text] [Related]
13. The refined crystal structure of Bacillus cereus oligo-1,6-glucosidase at 2.0 A resolution: structural characterization of proline-substitution sites for protein thermostabilization.
Watanabe K; Hata Y; Kizaki H; Katsube Y; Suzuki Y
J Mol Biol; 1997 May; 269(1):142-53. PubMed ID: 9193006
[TBL] [Abstract][Full Text] [Related]
14. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of Grb2-Sos1 interaction: the N-terminal SH3 domain of Grb2 mediates affinity.
Sastry L; Lin W; Wong WT; Di Fiore PP; Scoppa CA; King CR
Oncogene; 1995 Sep; 11(6):1107-12. PubMed ID: 7566970
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the SH3 domain of betaPIX in complex with a high affinity peptide from PAK2.
Hoelz A; Janz JM; Lawrie SD; Corwin B; Lee A; Sakmar TP
J Mol Biol; 2006 Apr; 358(2):509-22. PubMed ID: 16527308
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure analysis and solution studies of human Lck-SH3; zinc-induced homodimerization competes with the binding of proline-rich motifs.
Romir J; Lilie H; Egerer-Sieber C; Bauer F; Sticht H; Muller YA
J Mol Biol; 2007 Feb; 365(5):1417-28. PubMed ID: 17118402
[TBL] [Abstract][Full Text] [Related]
18. The 1.1 A resolution crystal structure of the p130cas SH3 domain and ramifications for ligand selectivity.
Wisniewska M; Bossenmaier B; Georges G; Hesse F; Dangl M; Künkele KP; Ioannidis I; Huber R; Engh RA
J Mol Biol; 2005 Apr; 347(5):1005-14. PubMed ID: 15784259
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of the PX domain, a target of the SH3 domain.
Hiroaki H; Ago T; Ito T; Sumimoto H; Kohda D
Nat Struct Biol; 2001 Jun; 8(6):526-30. PubMed ID: 11373621
[TBL] [Abstract][Full Text] [Related]
20. Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains.
Lim WA; Richards FM; Fox RO
Nature; 1994 Nov; 372(6504):375-9. PubMed ID: 7802869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
